Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis and central nervous system demyelination.

S Pouly1, J P Antel

  • 1Neuroimmunology Unit, Montréal Neurological Institute, 3801 University Street, Montréal, Québec, H3A 2B4, Canada.

Journal of Autoimmunity
|November 7, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

α7 nicotinic acetylcholine receptor signaling modulates the inflammatory phenotype of fetal brain microglia: first evidence of interference by iron homeostasis.

Scientific reports·2017
Same author

RNAseq profiling of primary microglia and astrocyte cultures in near-term ovine fetus: A glial in vivo-in vitro multi-hit paradigm in large mammalian brain.

Journal of neuroscience methods·2016
Same author

Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay.

Clinical immunology (Orlando, Fla.)·2010
Same author

Glatiramer acetate-reactive T lymphocytes regulate oligodendrocyte progenitor cell number in vitro: role of IGF-2.

Journal of neuroimmunology·2010
Same author

TLR-mediated B cell activation results in ectopic CLIP expression that promotes B cell-dependent inflammation.

Journal of leukocyte biology·2010
Same author

Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.

Glia·2007
Same journal

MuSK antibodies differently affect the MuSK signaling cascade depending on valency and epitope specificity.

Journal of autoimmunity·2026
Same journal

Neonatal total parenteral nutrition and the risk of childhood autoimmune diseases: A nationwide population-based study of 2.3 million children.

Journal of autoimmunity·2026
Same journal

Targeting autoreactive B cells in rheumatoid arthritis through MHC class I-presented BCR-derived neo-epitopes.

Journal of autoimmunity·2026
Same journal

Intermittent fasting ameliorates Sjögren's syndrome-related dry eye through a preponderant bile acid-Akkermansia homeostasis establishment.

Journal of autoimmunity·2026
Same journal

High-intensity immunosuppression versus modern standard care in poor-prognosis diffuse cutaneous systemic sclerosis: A propensity-matched study.

Journal of autoimmunity·2026
Same journal

Efficacy, safety, and tolerability of treatments for interstitial lung disease associated with rtoid arthritis: A systematic review and network meta-analysis.

Journal of autoimmunity·2026
See all related articles

Multiple sclerosis (MS) involves central nervous system (CNS) demyelination. Research suggests glial cell susceptibility to injury in MS may be targeted for neuroprotection.

Area of Science:

  • Neuroimmunology
  • Cellular Biology

Background:

  • Multiple sclerosis (MS) is a CNS demyelinating disease.
  • Lesion expansion in MS involves immune cells and glial cells.
  • Oligodendrocytes (OLs) and myelin are susceptible to injury in MS.

Purpose of the Study:

  • To investigate effector and target mechanisms of CNS injury in MS.
  • To explore the susceptibility of oligodendrocytes (OLs) to immune-mediated damage.
  • To identify potential targets for neuroprotective therapies in MS.

Main Methods:

  • Review of effector mechanisms including T cells, antibodies, NK cells, and gamma/delta T cells.
  • In vitro studies on oligodendrocyte (OL) injury.
  • Analysis of glial cell susceptibility based on receptor expression and signaling pathways.

Related Experiment Videos

Main Results:

  • T cells, antibodies, NK cells, and gamma/delta T cells can mediate OL injury.
  • OLs express MHC class I and are susceptible to CD8(+) T cell cytotoxicity.
  • TNF and CD95 mediate OL injury through differential glial cell susceptibility.

Conclusions:

  • MS lesion expansion involves diverse immune effector mechanisms.
  • Oligodendrocyte (OL) susceptibility to injury is influenced by both effector and target factors.
  • Target-determined susceptibility factors offer potential for neuroprotective strategies in MS.